BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25573224)

  • 1. Self-perceived health status of patients with adrenal insufficiency receiving glucocorticoid replacement therapy - French data from a worldwide patient survey.
    Touraine P; Chenuc G; Colin C
    Ann Endocrinol (Paris); 2015 Feb; 76(1):9-12. PubMed ID: 25573224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey.
    Forss M; Batcheller G; Skrtic S; Johannsson G
    BMC Endocr Disord; 2012 Jun; 12():8. PubMed ID: 22695167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
    Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic patient education in adrenal insufficiency.
    Guignat L
    Ann Endocrinol (Paris); 2018 Jun; 79(3):167-173. PubMed ID: 29606279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
    Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
    Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G; Falorni A; Skrtic S; Lennernäs H; Quinkler M; Monson JP; Stewart PM
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal glucocorticoid replacement in adrenal insufficiency.
    Øksnes M; Ross R; Løvås K
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):3-15. PubMed ID: 25617168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
    Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
    Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is physiological glucocorticoid replacement important in children?
    Porter J; Blair J; Ross RJ
    Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in primary and secondary adrenal insufficiency.
    Aulinas A; Webb SM
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):873-88. PubMed ID: 25252879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-management in adrenal insufficiency - towards a better understanding.
    Kampmeyer D; Haas CS; Moenig H; Harbeck B
    Endocr J; 2017 Apr; 64(4):379-385. PubMed ID: 28190868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies in adrenal insufficiency.
    Oelkers W; Diederich S; Bähr V
    Ann Endocrinol (Paris); 2001 Apr; 62(2):212-6. PubMed ID: 11353897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrocortisone replacement in disorders of sex development.
    Blankenstein O
    Endocr Dev; 2014; 27():160-71. PubMed ID: 25247653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.
    Watanabe T; Ozawa A; Ishii S; Tomaru T; Shibusawa N; Saito T; Yamada E; Horiguchi K; Nakajima Y; Matsumoto S; Yoshino S; Katano-Toki A; Hashimoto K; Mori M; Okada S; Satoh T; Yamada M
    Endocr J; 2018 May; 65(5):547-556. PubMed ID: 29618670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.